Metabolic Regulation of Toll-like Receptor Agonist Therapy in Leukemia

Toll 样受体激动剂治疗白血病的代谢调节

• 批准号: 170526
• 负责人: Spaner David E
• 金额: $ 27.73万
• 依托单位: Sunnybrook Research Institute (Toronto, Ontario)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2008
• 资助国家: 加拿大
• 起止时间: 2008-09-01 至 2011-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=170526&lang=en
• 关键词: Apoptosis; Cancer; Cytokines; Flow Cytometry; Glucose; Mitochondria

Chemotherapy does not cure most cancers. However, the results with chemotherapy may be improved with treatments that increase the ability of the immune system to kill cancer cells (or immunotherapy). We have found that a new agent (called S28690), which

化疗不能治愈大多数癌症。 然而，化疗的结果可以通过增加免疫系统杀死癌细胞的能力的治疗（或免疫疗法）来改善。我们发现了一种新的代理（称为S28690），